Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1494021

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1404861.].

What problem does this paper attempt to address?

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

DOI: https://doi.org/10.3389/fimmu.2021.782687

IF: 7.3

2021-10-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.676301.].

immunology
Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1532921

IF: 7.3

2024-12-12

Frontiers in Immunology

Abstract:This article is an erratum on: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

immunology
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology
Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1297519

IF: 7.3

2023-09-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1224516.].

immunology
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1261322

IF: 7.3

2023-07-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1067399.].

immunology
Erratum: γδ T cells as immunotherapy for malaria: balancing challenges and opportunities

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1364914

IF: 7.3

2024-01-11

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1242306.].

immunology
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Erratum: Trends in the global immuno-oncology landscape

Jun Tang,Laura Pearce,Jill O'Donnell-Tormey,Vanessa M. Hubbard-Lucey

DOI: https://doi.org/10.1038/nrd.2018.202

IF: 112.288

2018-01-01

Nature Reviews Drug Discovery

Abstract:Nature Reviews Drug Discovery 17, 783–784 (2018) In the original version of Figure 1, the label in the Y axis 'T cell-targeted' was incorrect and should be 'T cell-targeted immunomodulator'. The article has been corrected in the online version.
Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

DOI: https://doi.org/10.3233/BLC-219500

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200013.].
Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2021.754535

IF: 7.3

2021-08-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.692151.].

immunology
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology
Erratum: Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2021.832980

IF: 7.3

2021-12-24

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2018.01279.].

immunology
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Thomas Morgan Hulen,Christina Friese,Nikolaj Pagh Kristensen,Joachim Stoltenborg Granhøj,Troels Holz Borch,Marlies J W Peeters,Marco Donia,Mads Hald Andersen,Sine Reker Hadrup,Inge Marie Svane,Özcan Met

DOI: https://doi.org/10.3389/fimmu.2024.1462081

2024-07-18

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1180997.].
Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Anusha Thadi,Marian Khalili,William F Morano,Scott D Richard,Steven C Katz,Wilbur B Bowne

DOI: https://doi.org/10.3390/vaccines7010015

2019-01-31

Abstract:The authors wish to make the following corrections to this paper [...].
Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

DOI: https://doi.org/10.1183/23120541.50555-2020

2021-12-06

Abstract:[This corrects the article DOI: 10.1183/23120541.00555-2020.].
Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Longsha Liu,Thijs A van Schaik,Kok-Siong Chen,Filippo Rossignoli,Paulo Borges,Vladimir Vrbanac,Hiroaki Wakimoto,Khalid Shah

DOI: https://doi.org/10.3389/fimmu.2024.1466387

2024-08-05

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1324618.].
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.

Xiaowen Ma,Yang Song,Kuo Zhang,Lei Shang,Yuan Gao,Wei Zhang,Xiaochang Xue,Huimin Jia,Jian Geng,Wei Zhou,Yazheng Dang,Enxiao Li,Xinyu Ti,Fulin Fan,Yingqi Zhang,Meng Li

DOI: https://doi.org/10.1038/srep46953

IF: 4.6

2018-01-01

Scientific Reports

Abstract:This corrects the article DOI: 10.1038/srep09918.
Erratum: Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1469606

2024-08-01

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.965168.].

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Erratum: Approaching hemophagocytic lymphohistiocytosis

Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

Erratum: γδ T cells as immunotherapy for malaria: balancing challenges and opportunities

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Erratum: Trends in the global immuno-oncology landscape

Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components

Erratum: New insights into the role of macrophages in cancer immunotherapy

Erratum: Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54

Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.

Erratum: Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas